PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Aged nonhuman primates accumulate large amounts of human-sequence amyloid β (Aβ) in the brain, yet they do not manifest the full phenotype of Alzheimer’s disease (AD). To assess the biophysical properties of Aβ that might govern its pathogenic potential in humans and nonhuman primates, we incubated the benzothiazole imaging agent Pittsburgh compound B (PIB) with cortical tissue homogenates from normal aged humans, humans with AD, and from aged squirrel monkeys, rhesus monkeys, and chimpanzees with cerebral Aβ-amyloidosis. Relative to humans with AD, high-affinity PIB binding is markedly reduced in cortical extracts from aged nonhuman primates containing levels of insoluble Aβ similar to those in AD. The high-affinity binding of PIB may be selective for a pathologic, human-specific conformation of multimeric Aβ, and thus could be a useful experimental tool for clarifying the unique predisposition of humans to Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils
Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
Cummings, J. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040223 · Cited by 1,152
Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host
Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., et al. (2006) · Science · doi:10.1126/science.1131864 · Cited by 971
Self-citationPost-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 637
Wilcock, G. K., & Esiri, M. M. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90155-1 · Cited by 608
Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Kawas, C., Aronson, M., & Wolfson, L. (1988) · Neurology · doi:10.1212/wnl.38.11.1682 · Cited by 586
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495 · cited 1×
“…and high specificity, at concentrations typically achieved in imaging (~1 nM), to A β plaques and CAA (Klunk et al., 2003b, Bacskai et al., 2007, Johnson et al., 2007, Leinonen et al., 2008), but only weakly to neurofibrillary tangles and Lewy Bodies (Klunk et al., 2003b, Fodero-Tavoletti et…”
BackgroundPIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302
Research works printed but not linked: 29
- Arriagada, 1992, Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease, Neurology, 42, 1681, 10.1212/WNL.42.9.1681 · DOI · Paper page
- Bacskai, 2007, Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report, Arch. Neurol., 64, 431, 10.1001/archneur.64.3.431 · DOI · Paper page
- Chien, 2004, Emerging principles of conformation-based prion inheritance, Annu. Rev. Biochem., 73, 617, 10.1146/annurev.biochem.72.121801.161837 · DOI · Paper page
- Collinge, 2007, A general model of prion strains and their pathogenicity, Science, 318, 930, 10.1126/science.1138718 · DOI · Paper page
- Dodart, 2005, Overview on rodent models of Alzheimer's disease, Curr. Protoc. Neurosci., 10.1002/0471142301.ns0922s33 · DOI · Paper page
- Elfenbein, 2007, Cerebral beta-amyloid angiopathy in aged squirrel monkeys, Histol. Histopathol., 22, 155
- Fodero-Tavoletti, 2007, In vitro characterization of Pittsburgh Compound-B binding to Lewy bodies, J. Neurosci., 27, 10365, 10.1523/JNEUROSCI.0630-07.2007 · DOI · Paper page
- Giannakopoulos, 2007, Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience, Acta Neuropathol. (Berl.), 113, 1, 10.1007/s00401-006-0144-y · DOI · Paper page
- Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Hasegawa, 1999, Interaction between A beta(1–42) and A beta(1–40) in Alzheimer's beta-amyloid fibril formation in vitro, Biochemistry, 38, 15514, 10.1021/bi991161m · DOI · Paper page
- Klunk, 2003, The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component, J. Neurosci., 23, 2086, 10.1523/JNEUROSCI.23-06-02086.2003 · DOI · Paper page
- Klunk, 2005, Binding of the positron emission tomography tracer Pittsburgh Compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain, J. Neurosci., 25, 10598, 10.1523/JNEUROSCI.2990-05.2005 · DOI · Paper page
- Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann. Neurol., 55, 306, 10.1002/ana.20009 · DOI · Paper page
- Kuo, 2001, Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains, J. Biol. Chem., 276, 12991, 10.1074/jbc.M007859200 · DOI · Paper page
- LeVine, 2008, Molecular polymorphism of Abeta in Alzheimer's disease, Neurobiol. Aging
- Makarava, 2008, The same primary structure of the prion protein yields two distinct self-propagating states, J. Biol. Chem., 283, 15988, 10.1074/jbc.M800562200 · DOI
- Mathis, 2004, Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain, Curr. Pharm. Des., 10, 1469, 10.2174/1381612043384772 · DOI · Paper page
- Noda, 2008, Amyloid imaging in aged and young macaques with [11C]PIB and [18F]FDDNP, Synapse, 62, 472, 10.1002/syn.20508 · DOI · Paper page
- Nordberg, 2008, Amyloid plaque imaging in vivo: current achievement and future prospects, Eur. J. Nucl. Med. Mol. Imag., 35, S46, 10.1007/s00259-007-0700-2 · DOI
- Otvos, 1993, Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents, Eur. J. Biochem., 211, 249, 10.1111/j.1432-1033.1993.tb19893.x · DOI · Paper page
- Rosen, 2008, Tauopathy with paired helical filaments in an aged chimpanzee, J. Comp. Neurol., 509, 259, 10.1002/cne.21744 · DOI · Paper page
- Serdons, 2009, Synthesis of 18F-labelled 2-(4′-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB, Bioorg. Med. Chem. Lett., 19, 602, 10.1016/j.bmcl.2008.12.069 · DOI
- Svedberg, 2008, [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients, Neurochem. Int., 54, 347, 10.1016/j.neuint.2008.12.016 · DOI
- Toyama, 2005, PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease, Eur. J. Nucl. Med. Mol. Imag., 32, 593, 10.1007/s00259-005-1780-5 · DOI
- Vinters, 1996, Brain parenchymal and microvascular amyloid in Alzheimer's disease, Brain Pathol., 6, 179, 10.1111/j.1750-3639.1996.tb00799.x · DOI · Paper page
- Walker, 2000, Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly, Acta Neuropathol., 100, 36, 10.1007/s004010051190 · DOI
- Ye, 2006, Characterisation of the binding of amyloid imaging tracers to rodent Abeta fibrils and rodent-human Abeta co-polymers, Biochem. Biophys. Res. Commun., 347, 669, 10.1016/j.bbrc.2006.06.126 · DOI
- Ye, 2005, Delineation of positron emission tomography imaging agent binding sites on beta-amyloid peptide fibrils, J. Biol. Chem., 280, 23599, 10.1074/jbc.M501285200 · DOI · Paper page
- Ye, 2008, In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain, J. Neurochem., 105, 1428, 10.1111/j.1471-4159.2008.05245.x · DOI · Paper page
Cited by
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
“Only very low stoichiometry PIB binding is seen in unaffected regions of AD brain or any region of the plaque-rich transgenic mouse brain (Klunk, Rosen, LeVine, and Walker, unpublished results) or in non-human primate temporal or parietal cortex containing similar amounts of insolubleA β [85].”
Self-citationAlzheimer's disease: experimental models and reality
Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810
“Aβ levels accumulate with age, reaching similar levels in the cortex to that observed in human AD, and there is often more Aβ42 than Aβ40 [126].”
BackgroundInfluentialTau imaging: early progress and future directions
Villemagne, V. L., Fodero-Tavoletti, M. T., Masters, C. L., & Rowe, C. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70252-2 · Cited by 501
Jucker, M. (2010) · Nature Medicine · doi:10.1038/nm.2224 · Cited by 401
Neurodegenerative Diseases: Expanding the Prion Concept
Walker, L. C., & Jucker, M. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033828 · Cited by 361
“…can form strain-like variants in vitro (Mehta et al. 2013; Meinhardt et al. 2009; Nilsson et al. 2007; Paravastu et al. 2008, 2009; Petkova et al. 2005) and in vivo (Heilbronner et al. 2013; Lu et al. 2013; Meyer-Luehmann et al. 2006; Rosen et al. 2010, 2011; Stöhr et al. 2014; Watts et al. 2014).”
BackgroundSelf-citation
Metadata
- Authors
- Rosen, R. F., Walker, L. C., & LeVine, H.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 32
- Issue
- 2
- Pages
- 223-234
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2017622907
- Cited by
- 97
- References
- 14
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2009.02.011
- The paper
- Rosen, R. F., Walker, L. C., & LeVine, H. (2011). PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2009.02.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.